Dolutegravir and lamivudine (Oral)
Generic Name: dolutegravir/lamivudine (doe-loo-TEG-ra-vir, la-MIV-ue-deen)
Warning: Patients Co-Infected with Hepatitis B Virus (HBV) and Human Immunodeficiency Virus (HIV-1): Emergence of Lamivudine-Resistant HBV and Exacerbations of HBVAll patients with HIV-1 should be tested for the presence of HBV prior to or when initiating dolutegravir/lamivudine. Emergence of lamivudine-resistant HBV variants associated with lamivudine-containing antiretroviral regimens has been reported. If dolutegravir/lamivudine is used in patients co-infected with HIV-1 and HBV, additional treatment should be considered for appropriate treatment of chronic HBV; otherwise, consider an alternative regimen. Severe acute exacerbations of HBV have been reported in patients who are co-infected with HIV-1 and HBV and have discontinued lamivudine, a component of dolutegravir/lamivudine. Closely monitor hepatic function in these patients and, if appropriate, initiate anti-HBV treatment .
Medically reviewed by Drugs.com. Last updated on Oct 26, 2020.
Commonly used brand name(s)
In the U.S.
Available Dosage Forms:
Therapeutic Class: Antiretroviral Agent
Pharmacologic Class: Integrase Inhibitor
Uses for dolutegravir and lamivudine
Dolutegravir and lamivudine combination is used to treat human immunodeficiency virus (HIV) infection. HIV is the virus that causes acquired immune deficiency syndrome (AIDS).
Dolutegravir and lamivudine combination will not cure or prevent HIV infection or AIDS. It works by lowering the amount of HIV in the blood and will also help your immune system. This may help delay some of the medical conditions that usually result from AIDS or HIV disease. Dolutegravir and lamivudine combination will not keep you from spreading HIV to other people.
Dolutegravir and lamivudine is available only with your doctor's prescription.
Before using dolutegravir and lamivudine
In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For dolutegravir and lamivudine, the following should be considered:
Tell your doctor if you have ever had any unusual or allergic reaction to dolutegravir and lamivudine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.
Appropriate studies have not been performed on the relationship of age to the effects of dolutegravir and lamivudine combination in the pediatric population. Safety and efficacy have not been established.
Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of dolutegravir and lamivudine combination in the elderly. However, elderly patients are more likely to have age-related liver, kidney, or heart problems, which may require caution for patients receiving dolutegravir and lamivudine.
There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.
Interactions with medicines
Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking dolutegravir and lamivudine, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.
Using dolutegravir and lamivudine with any of the following medicines is not recommended. Your doctor may decide not to treat you with this medication or change some of the other medicines you take.
Using dolutegravir and lamivudine with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.
- Eslicarbazepine Acetate
- St John's Wort
Interactions with food/tobacco/alcohol
Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.
Other medical problems
The presence of other medical problems may affect the use of dolutegravir and lamivudine. Make sure you tell your doctor if you have any other medical problems, especially:
- Hepatitis B or C infection—Use with caution. May make this condition worse.
- Kidney disease, severe or
- Liver disease, severe—Use is not recommended in patients with these conditions.
Proper use of dolutegravir and lamivudine
Use dolutegravir and lamivudine exactly as directed by your doctor. Do not use more of it, do not use it more often, and do not use it for a longer time than your doctor ordered. Also, do not change the dose or stop using dolutegravir and lamivudine without checking first with your doctor. When your supply of dolutegravir and lamivudine is running low, contact your doctor or pharmacist ahead of time. Do not allow yourself to run out of dolutegravir and lamivudine.
Dolutegravir and lamivudine comes with a patient information leaflet. Read and follow these instructions carefully. Ask your doctor if you have any questions.
Keep using dolutegravir and lamivudine for the full time of treatment, even if you begin to feel better. It is also important to take dolutegravir and lamivudine together with other medicines for HIV. Be sure to take all of the medicines your doctor ordered, and to take them at the right times.
Dolutegravir and lamivudine combination contains a fixed amount of each medicine in the tablet.
You may take dolutegravir and lamivudine with or without food.
Take dolutegravir and lamivudine at least 2 hours before or 6 hours after take sucralfate, an antacid or laxative that contains aluminum, calcium, or magnesium, or a buffered medicine.
You may take calcium or iron supplements together with dolutegravir and lamivudine if you take them with food. If not, take dolutegravir and lamivudine 2 hours before or 6 hours after you take these supplements.
The dose of dolutegravir and lamivudine will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of dolutegravir and lamivudine. If your dose is different, do not change it unless your doctor tells you to do so.
The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.
- For oral dosage form (tablets):
- For HIV infection:
- Adults—One tablet once a day. Each tablet contains 50 milligrams (mg) dolutegravir and 300 mg lamivudine.
- Children—Use and dose must be determined by your doctor.
- For HIV infection:
If you miss a dose of dolutegravir and lamivudine, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.
Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.
Keep out of the reach of children.
Do not keep outdated medicine or medicine no longer needed.
Ask your healthcare professional how you should dispose of any medicine you do not use.
Precautions while using dolutegravir and lamivudine
It is very important that your doctor check your progress at regular visits to make sure dolutegravir and lamivudine is working properly. Blood and urine tests may be needed to check for unwanted effects.
Do not use dolutegravir and lamivudine together with dofetilide (Tikosyn®). Using these medicines together may cause serious or life-threatening side effects.
It is important to tell your doctor if you are pregnant or planning to become pregnant before using dolutegravir and lamivudine. Using dolutegravir and lamivudine while you are pregnant can harm your unborn baby. Do not use dolutegravir and lamivudine during the first part of your pregnancy unless your doctor tells you to.
Serious allergic reactions may occur while you are using dolutegravir and lamivudine. Check with your doctor right away if you have the following symptoms: a severe rash or rash with fever, blistering or peeling skin, diarrhea, nausea, vomiting, joint or muscle pain, sores in the mouth, swelling of the face, troubled breathing, unusual tiredness or weakness, or yellow eyes or skin.
Two rare but serious reactions to dolutegravir and lamivudine are lactic acidosis (too much acid in the blood) and liver toxicity, which includes an enlarged liver. These are more common if you are female, very overweight (obese), or have been taking anti-HIV medicines for a long time. Call your doctor right away if you have more than one of these symptoms: abdominal or stomach discomfort or cramping, dark urine, decreased appetite, diarrhea, general feeling of discomfort, light-colored stools, muscle cramping or pain, nausea, unusual tiredness or weakness, troubled breathing, vomiting, or yellow eyes or skin.
Your immune system may get stronger when you start taking HIV medicines. Tell your doctor right away if you notice any changes in your health. Sometimes the immune system will start to fight infections that were hidden in your body, such as pneumonia or tuberculosis. Autoimmune disorders (eg, Graves' disease, polymyositis, or Guillain-Barré syndrome) may also occur.
Dolutegravir and lamivudine will not keep you from giving HIV to your partner during sex. Make sure you understand this and practice safe sex, even if your partner also has HIV, by using a latex condom or other barrier method. Dolutegravir and lamivudine will also not keep you from giving HIV to other people if they are exposed to your blood. Do not re-use or share needles with anyone.
Do not take other medicines unless they have been discussed with your doctor. This includes prescription or nonprescription (over-the-counter [OTC]) medicines and herbal (eg, St. John's wort) or vitamin supplements.
Dolutegravir and lamivudine side effects
Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur:
- Black, tarry stools
- bleeding gums
- bloody urine
- dark urine
- decreased frequency or amount of urine
- fast heartbeat
- general feeling of tiredness and weakness
- hives, itching, skin rash
- increased blood pressure
- increased thirst
- joint pain, stiffness, or swelling
- light-colored stools
- loss of appetite
- lower back or side pain
- painful or difficult urination
- pale skin
- pinpoint red spots on the skin
- redness of the skin
- sore throat
- stomach discomfort or pain
- swelling of the eyelids, face, lips, hands, or feet
- tightness in the chest
- troubled breathing or swallowing
- troubled breathing with exertion
- ulcers, sores, or white spots in the mouth
- unusual bleeding or bruising
- unusual tiredness or weakness
- upper right abdominal pain
- weight gain
- yellow eyes and skin
Incidence not known
- Blurred vision
- dry mouth
- fast, shallow breathing
- flushed, dry skin
- fruit-like breath odor
- increased hunger
- increased urination
- light-colored stools
- muscle cramps, pain, stiffness, or spasms
- stomach pain, continuing
- unexplained weight loss
Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
- Abnormal dreams
- bloated or full feeling
- excess air or gas in the stomach or bowels
- feeling sad or empty
- loss of interest or pleasure
- passing gas
- thoughts or attempts at killing oneself
- trouble concentrating
- trouble sleeping
Incidence not known
- Burning, crawling, itching, numbness, prickling, "pins and needles", or tingling feelings
- difficulty in moving
- hair loss or thinning of hair
- redistribution of body fat
Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.
Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
More about dolutegravir / lamivudine
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Interactions
- En Español
- 8 Reviews
- Drug class: antiviral combinations
- FDA Alerts (1)
- Other brands
Related treatment guides
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.